Fundraising FoxLouisiana Funds — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Calosyn Pharmacalosynpharma.comDec 2022
Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
BiotechShreveport, US
William R. Grimes(President and Chief Executive Officer)Stephen Snowdy(Executive Officer, Director)David Waddell(Director)
BoardJoseph Lovett(Director)inRichard Babb(Treasurer)inMike Sherman(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.